Clinical trial
Dalteparin Versus Unfractionated Heparin In Patients With Acute Coronary…
NCT00435487 · Pfizer, Industry · Terminated
Key facts
| NCT number | NCT00435487 |
|---|---|
| Title | Dalteparin Versus Unfractionated Heparin In Patients With Acute Coronary Syndrome |
| Official title | Prospective Randomized Phase IV Open Label Comparative Study Of Dalteparin vs Unfractionated Heparin In High Risk Patients Of Non-ST Elevation Acute Coronary Syndromes Intended For Early Invasive Strategy |
| Lead sponsor | Pfizer, Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Angina, Unstable, Myocardial Infarction |
| Intervention type | Drug |
| Interventions | Dalteparin ( Fragmin), Unfractionated heparin |
| Enrollment | 173 |
| Start date | Jun 1, 2007 |
| Primary completion | Dec 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Feb 15, 2007 |
| Last update posted | Oct 17, 2011 |
| Countries | India |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: